HomeCompareXFTB vs JNJ

XFTB vs JNJ: Dividend Comparison 2026

XFTB yields 1000000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XFTB wins by $4.7683925249533696e+36M in total portfolio value
10 years
XFTB
XFTB
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full XFTB calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — XFTB vs JNJ

📍 XFTB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXFTBJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XFTB + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XFTB pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XFTB
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, XFTB beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XFTB + JNJ for your $10,000?

XFTB: 50%JNJ: 50%
100% JNJ50/50100% XFTB
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

XFTB
No analyst data
Altman Z
-10.8
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XFTB buys
0
JNJ buys
0
No recent congressional trades found for XFTB or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXFTBJNJ
Forward yield1000000.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$4.7683925249533696e+36M$20.0K
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$827.78
Total dividends collected$4.7683311610149396e+36M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: XFTB vs JNJ ($10,000, DRIP)

YearXFTB PortfolioXFTB Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$100,010,700$100,000,000.00$10,676$355.77+$100.00MXFTB
2$934,786,450,701$934,679,439,252.34$11,407$389.39+$934786.44MXFTB
3$8,165,787,108,578,292$8,164,786,887,076,042.00$12,198$426.53+$8165787108.57MXFTB
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$13,056$467.62+$66665884190957.63MXFTB
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$13,987$513.12+$508662171058048128.00MXFTB
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$14,998$563.56+$3.62723524842849e+21MXFTB
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$16,098$619.52+$2.417368115915061e+25MXFTB
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$17,295$681.69+$1.5056740286145463e+29MXFTB
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$18,599$750.82+$8.764771002818475e+32MXFTB
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$20,022$827.78+$4.7683925249533696e+36MXFTB

XFTB vs JNJ: Complete Analysis 2026

XFTBStock

XFit Brands, Inc. designs, develops, markets, and sells functional equipment, training gears, and apparel and accessories for the impact sports market and fitness industry worldwide. It offers functional fitness stations, including XTC, CTC, and UTC training equipment, as well as mobile fitness training stations used in set up for mobile events, such as mobile boot camps, community events, trade shows, and outdoor competitions. The company also provides training and protective gears comprising mixed martial arts and boxing gloves, punching mitts, thai pads, body shields, and heavy bags; cages and rings to ultimate fighting championship gyms; and bag rack systems. In addition, it offers apparel; functional training equipment and accessories consisting of weight plates, kettle bells, resistance bands, weight bars and dumbbells, jump ropes, slam balls, and plyometrix boxes used in cross training and other related fitness regimens; and fitness training programs. The company provides its products under the Throwdown, XFit Brands, and Transformations brand names. XFit Brands, Inc. markets and sells its products through various channels, including gyms, fitness facilities, third party catalogues, independent distributors, and licensees, as well as directly to consumers through its Website. The company was founded in 2003 and is based in Lake Forest, California.

Full XFTB Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this XFTB vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XFTB vs SCHDXFTB vs JEPIXFTB vs OXFTB vs KOXFTB vs MAINXFTB vs ABBVXFTB vs MRKXFTB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.